What are the Challenges in Cancer Drug Development?
Developing new cancer drugs is fraught with challenges. These include the heterogeneity of cancer, where different patients may have different mutations even within the same type of cancer. Additionally, drug resistance can develop, rendering treatments ineffective over time. High costs and the lengthy timeline for development also pose significant barriers. Despite these challenges, advancements in precision medicine and immunotherapy offer promising new avenues for treatment.
